Clinical Trial Update: Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes tinzaparin as a treatment for metastatic kidney cancer that cannot be removed surgically. The study spans Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• tinzaparin (tinzaparin)

Snippet

Sponsor: University of Vermont | Conditions: Kidney Cancer | Phase 1, Phase 2 | Status: UNKNOWN